{
    "organizations": [],
    "uuid": "97d1b50750ee5a52ecdc03f7b29fce8282f065c8",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-concert-pharmaceuticals-initiates/brief-concert-pharmaceuticals-initiates-enrollment-in-second-cohort-of-ctp-543-trial-idUSASB0C551",
    "ord_in_thread": 0,
    "title": "BRIEF-Concert Pharmaceuticals Initiates Enrollment In Second Cohort Of CTP-543 Trial",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 12 (Reuters) - Concert Pharmaceuticals Inc:\n* CONCERT PHARMACEUTICALS ANNOUNCES INITIATION OF ENROLLMENT IN SECOND COHORT OF CTP-543 PHASE 2A TRIAL FOR ALOPECIA AREATA\n* CONCERT PHARMACEUTICALS INC - PHASE 2A TRIAL ON TRACK TO COMPLETE IN SECOND HALF OF 2018 Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-12T20:16:00.000+02:00",
    "crawled": "2018-02-13T15:42:21.005+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "concert",
        "pharmaceutical",
        "inc",
        "concert",
        "pharmaceutical",
        "announces",
        "initiation",
        "enrollment",
        "second",
        "cohort",
        "phase",
        "2a",
        "trial",
        "alopecia",
        "areata",
        "concert",
        "pharmaceutical",
        "inc",
        "phase",
        "2a",
        "trial",
        "track",
        "complete",
        "second",
        "half",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}